Day: September 21, 2021

Strategic partnership between Black Diamond and OpenEye aims to accelerate drug discovery efforts through cloud-based molecular dynamics technology CAMBRIDGE, Mass. and SANTA FE, N.M., Sept. 21, 2021 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, and OpenEye Scientific, a leader in computational molecular design, today announced that they are entering into a strategic partnership incorporating OpenEye’s Orion® molecular design platform into Black Diamond’s proprietary Mutation-Allostery-Pharmacology (MAP) drug discovery engine to advance Black Diamond’s efforts to develop MasterKey inhibitor cancer therapies. OpenEye’s Orion Software-as-a-Service platform will enable Black Diamond to perform rapid simulations and analysis of protein...

Los Angeles, CA., Sept. 21, 2021 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce that its Vital Intelligence Smart Vital system has been integrated into Fobi AI Inc.’s (“Fobi”) (TSXV: FOBI) Venue Management System for Conferences & Events. The venue management platform will now consist of Draganfly’s Smart Vital assessment system, Fobi’s Passcreator mobile Wallet passes, proprietary Smart Tap Devices, Smart Scan Pass Validation App and Insight Portal for event analytics. Prior to an event, Fobi allows organizers to prompt guests to complete health screening on their phones. Using the phone’s camera, Draganfly’s Smart Vital system monitors, with voluntary consent, vital...

VANCOUVER, British Columbia, Sept. 21, 2021 (GLOBE NEWSWIRE) — Fobi AI Inc. (formerly Loop Insights Inc.) (TSXV: FOBI) (OTCQB: FOBIF) (the “Company” or “Fobi“), a global leader in providing real-time data analytics through artificial intelligence to drive customer activation and engagement is pleased to announce that Draganfly’s (NASDAQ: DPRO) Vital Intelligence Smart Vital system has been integrated into Fobi’s Venue Management System for Conferences & Events. Fobi’s venue management platform will now offer Draganfly’s Smart Vital assessment system as a key product offering to Fobi’s Passcreator mobile Wallet passes, proprietary Smart Tap Devices, Smart Scan Pass Validation App and Insight Portal for event analytics. Prior to an event, Fobi enables organizers to prompt their guests to complete health...

Det kan oplyses, at den 20. september i perioden fra ca. kl. 9:45 til ca. kl. 11:23 har været fejl i de offentliggjorte indre værdier i nedenstående afdelinger, grundet en fejlagtig futures korrektion:Afdelingsnavn ISIN Fejl (undervurderet)K Invest Globale Small Cap Aktier DK0060636595 -0,61%Advice Capital Globale DK0060696656 -0,58%Afsluttende kan det oplyses, at børsmæglerforeningen er orienteret herom. Eventuel henvendelse vedrørende denne meddelelse kan rettes til NPA.PM@nykredit.dk eller JNA@nykredit.dk.  Med venlig hilsenNykredit Portefølje Administration A/S Tage Fabrin-Brasted Direktørtlf. 44 55 91 60mail tfb@nykredit.dk

Represents Another Important Milestone as Company Executes on Plan to Return to Normalized Financial Reporting BEIJING, Sept. 21, 2021 (GLOBE NEWSWIRE) — Luckin Coffee Inc. (in Provisional Liquidation) (“Luckin Coffee” or the “Company”) (OTC: LKNCY) today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 (the “2020 Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”). 2020 FISCAL YEAR HIGHLIGHTSNet revenues of RMB4,033.4 million (US$618.1 million), representing an increase of 33.3% compared to 2019, which was achieved despite the impact of COVID-19 in 2020 and primarily driven by the increased average selling price for Luckin Coffee’s high-quality products. Operating expenses of RMB6,620.7 million (US$1,014.7 million), which was in line with the Company’s...

Scheme Related to Restructuring of Convertible Senior Notes Due 2025 BEIJING, Sept. 21, 2021 (GLOBE NEWSWIRE) — Luckin Coffee Inc. (in Provisional Liquidation) (“Luckin Coffee” or the “Company”) (OTC: LKNCY) today announced that it has filed a petition and summons for directions in the Grand Court of the Cayman Islands (the “Cayman Court”) regarding a scheme of arrangement (the “Scheme”) related to the restructuring of its $460 million 0.75% Convertible Senior Notes due 2025 (the “Existing Notes”) proposed by Luckin Coffee and its Joint Provisional Liquidators.1 Pursuant to the summons for directions, the Company seeks an order for the convening of a single meeting of the class of creditors affected by the Scheme (the “Scheme Creditors”) to consider and, if thought fit, approve, with or without modification, the Scheme (the “Convening...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA. HARGREAVE HALE AIM VCT PLC LEI: 213800LRYA19A69SIT31         21 September 2021 Offer update – close of early bird discount The Board of Hargreave Hale AIM VCT plc (the “Company”) announced on 2 September 2021 that the Company had published a prospectus in relation to an offer for subscription to raise up to £20 million, together with an over-allotment facility to raise up to a further £20 million (the “Offer”). Under the Offer,...

WARMINSTER, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection, as well as therapies to treat coronaviruses (including COVID-19), today announced the Company has appointed Lisa M. Caperelli to the newly created position of Vice President of Investor Relations, leading investor relations strategy and communications activities, reporting to David Hastings, Arbutus’ Chief Financial Officer. “We are excited to welcome Lisa to the management team as she brings a wealth of experience in running highly effective investor relations and communications programs in the life sciences industry,” commented David Hastings. “We...